Larvol Delta - A-Study-Evaluating-ANV600-Single-Agent-or-in-Combination-With-Pembrolizumab-in-Participants-With-Advanced-Solid-Tumors-EXPAND1

ANV600 - Anaveon

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT06470763

Jun 24, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next